These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 30309225)

  • 1. Non-Vitamin K Oral Anticoagulants Associated Bleeding and Its Antidotes.
    Steiner T; Köhrmann M; Schellinger PD; Tsivgoulis G
    J Stroke; 2018 Sep; 20(3):292-301. PubMed ID: 30309225
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Specific antidotes against direct oral anticoagulants: A comprehensive review of clinical trials data.
    Tummala R; Kavtaradze A; Gupta A; Ghosh RK
    Int J Cardiol; 2016 Jul; 214():292-8. PubMed ID: 27082776
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reversal of oral anticoagulation in patients with acute intracerebral hemorrhage.
    Kuramatsu JB; Sembill JA; Huttner HB
    Crit Care; 2019 Jun; 23(1):206. PubMed ID: 31171018
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Management of oral anticoagulation related intracerebral hemorrhage].
    Sembill JA; Kuramatsu JB; Hohnloser SH; Huttner HB
    Herz; 2019 Jun; 44(4):315-323. PubMed ID: 30941474
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effectiveness and Safety of Non-vitamin K Antagonist Oral Anticoagulants for Atrial Fibrillation and Venous Thromboembolism: A Systematic Review and Meta-analyses.
    Almutairi AR; Zhou L; Gellad WF; Lee JK; Slack MK; Martin JR; Lo-Ciganic WH
    Clin Ther; 2017 Jul; 39(7):1456-1478.e36. PubMed ID: 28668628
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of major bleeding complications and emergency surgery in patients on long-term treatment with direct oral anticoagulants, thrombin or factor-Xa inhibitors: proposals of the working group on perioperative haemostasis (GIHP) - March 2013.
    Pernod G; Albaladejo P; Godier A; Samama CM; Susen S; Gruel Y; Blais N; Fontana P; Cohen A; Llau JV; Rosencher N; Schved JF; de Maistre E; Samama MM; Mismetti P; Sié P;
    Arch Cardiovasc Dis; 2013; 106(6-7):382-93. PubMed ID: 23810130
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characteristics of Symptomatic Intracranial Hemorrhage in Patients Receiving Non-Vitamin K Antagonist Oral Anticoagulant Therapy.
    Akiyama H; Uchino K; Hasegawa Y
    PLoS One; 2015; 10(7):e0132900. PubMed ID: 26171862
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bleeding with dabigatran, rivaroxaban, apixaban. No antidote, and little clinical experience.
    Prescrire Int; 2013 Jun; 22(139):155-9. PubMed ID: 23866358
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lupus-anticoagulant testing at NOAC trough levels.
    Ratzinger F; Lang M; Belik S; Jilma-Stohlawetz P; Schmetterer KG; Haslacher H; Perkmann T; Quehenberger P
    Thromb Haemost; 2016 Aug; 116(2):235-40. PubMed ID: 27075441
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Non-vitamin K dependent oral anticoagulants : What is important in intensive care medicine].
    Gulba DC; Broscaru L
    Med Klin Intensivmed Notfmed; 2017 Mar; 112(2):83-91. PubMed ID: 28144727
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Laboratory Monitoring of Non-Vitamin K Antagonist Oral Anticoagulant Use in Patients With Atrial Fibrillation: A Review.
    Eikelboom JW; Quinlan DJ; Hirsh J; Connolly SJ; Weitz JI
    JAMA Cardiol; 2017 May; 2(5):566-574. PubMed ID: 28355459
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Role of FEIBA in Reversing Novel Oral Anticoagulants in Intracerebral Hemorrhage.
    Dibu JR; Weimer JM; Ahrens C; Manno E; Frontera JA
    Neurocrit Care; 2016 Jun; 24(3):413-9. PubMed ID: 26545367
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fatal oral anticoagulant-related intracranial hemorrhage: a systematic review and meta-analysis.
    Katsanos AH; Schellinger PD; Köhrmann M; Filippatou A; Gurol ME; Caso V; Paciaroni M; Perren F; Alexandrov AV; Tsivgoulis G
    Eur J Neurol; 2018 Oct; 25(10):1299-1302. PubMed ID: 29953696
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trends in incidence of oral anticoagulant-related intracerebral hemorrhage and sales of oral anticoagulants in Capital Region of Denmark 2010-2017.
    Grundtvig J; Ovesen C; Havsteen I; Christensen T; Gaist D; Iversen HK; Kruuse C; Lilja-Cyron A; Ægidius K; Rosenbaum S; Meden P; Marstrand J; Christensen L; Steiner T; Christensen H
    Eur Stroke J; 2021 Jun; 6(2):143-150. PubMed ID: 34414289
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New Insights into Nonvitamin K Antagonist Oral Anticoagulants' Reversal of Intracerebral Hemorrhage.
    Yasaka M
    Front Neurol Neurosci; 2015; 37():93-106. PubMed ID: 26588018
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monitoring and reversal strategies for new oral anticoagulants.
    Vanden Daelen S; Peetermans M; Vanassche T; Verhamme P; Vandermeulen E
    Expert Rev Cardiovasc Ther; 2015 Jan; 13(1):95-103. PubMed ID: 25431993
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-vitamin K antagonist oral anticoagulants in cardiovascular disease management: evidence and unanswered questions.
    Cheng JW; Barillari G
    J Clin Pharm Ther; 2014 Apr; 39(2):118-35. PubMed ID: 24383983
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anticoagulation reversal in the era of the non-vitamin K oral anticoagulants.
    Enriquez A; Lip GY; Baranchuk A
    Europace; 2016 Jul; 18(7):955-64. PubMed ID: 25816811
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Race against the clock: overcoming challenges in the management of anticoagulant-associated intracerebral hemorrhage.
    Le Roux P; Pollack CV; Milan M; Schaefer A
    J Neurosurg; 2014 Aug; 121 Suppl():1-20. PubMed ID: 25081496
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of bleeding in patients receiving non-vitamin K antagonists.
    Balla S; Koerber S; Flaker G
    Postgrad Med J; 2017 Apr; 93(1098):221-225. PubMed ID: 27986971
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.